口服地塞米松不使用抗生素与安慰剂对成人急性咽痛的影响:一项随机临床试验
这项双盲、安慰剂对照随机试验在英格兰南部和西部42家家庭诊所纳入576名因急性咽痛就诊且不需立即使用抗生素的成人,比较单次口服地塞米松10 mg与安慰剂。24小时症状完全缓解率两组无显著差异,但48小时地塞米松组高于安慰剂组。
要点
- 24小时症状完全缓解率地塞米松组22.6% vs 安慰剂组17.7%,差异未达统计学显著。
- 48小时症状完全缓解率地塞米松组35.4% vs 安慰剂组27.1%,差异有统计学意义。
- 其他次要结局两组无显著差异。
核心结论
- 在因急性咽痛就诊于初级保健的成人中,与安慰剂相比,单次口服地塞米松未增加24小时症状缓解的患者比例,但48小时存在显著差异。
研究设计与样本
- 双盲、安慰剂对照随机试验,于2013年4月至2015年2月在英格兰南部和西部42家家庭诊所开展,随访28天于2015年4月完成。
- 共纳入576名因急性咽痛就诊于初级保健且不需立即抗生素治疗的成人,随机接受单次口服地塞米松10 mg(n=293)或相同安慰剂(n=283)。
- 565名符合条件并随机化的参与者中,288名接受地塞米松,277名接受安慰剂;中位年龄34岁(四分位距26.0-45.5岁),女性占75.2%,100%完成干预。
主要发现
- 24小时症状完全缓解:地塞米松组65名(22.6%)vs 安慰剂组49名(17.7%),风险差4.7%(95%CI -1.8%至11.2%),相对危险度1.28(95%CI 0.92至1.78;P=0.14)。
- 48小时症状完全缓解:地塞米松组102名(35.4%)vs 安慰剂组75名(27.1%),风险差8.7%(95%CI 1.2%至16.2%),相对危险度1.31(95%CI 1.02至1.68;P=0.03)。
- 在未提供延迟抗生素处方的参与者中,48小时风险差10.3%(95%CI 0.6%至20.1%),相对危险度1.37(95%CI 1.01至1.87;P=0.046)。
- 其他次要结局两组均无显著差异。
关键数值与推荐
- 主要结局为24小时症状完全缓解比例。
- 次要结局包括48小时完全缓解、中度严重症状持续时间(基于Likert量表,0为正常,6为最严重)、视觉模拟症状量表(0-100 mm,0为无症状,100为最严重)、就医次数、因病缺勤天数、延迟抗生素或其他药物使用、不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acute sore throat poses a significant burden on primary care and is a source of inappropriate antibiotic prescribing. Corticosteroids could be an alternative symptomatic treatment. OBJECTIVE: To assess the clinical effectiveness of oral corticosteroids for acute sore throat in the absence of antibiotics. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled randomized trial (April 2013-February 2015; 28-day follow-up completed April 2015) conducted in 42 family practices in South and West England, enrolled 576 adults recruited on the day of presentation to primary care with acute sore throat not requiring immediate antibiotic therapy. INTERVENTIONS: Single oral dose of 10 mg of dexamethasone (n = 293) or identical placebo (n = 283). MAIN OUTCOMES AND MEASURES: Primary: proportion of participants experiencing complete resolution of symptoms at 24 hours. Secondary: complete resolution at 48 hours, duration of moderately bad symptoms (based on a Likert scale, 0, normal; 6, as bad as it could be), visual analog symptom scales (0-100 mm; 0, no symptom to 100, worst imaginable), health care attendance, days missed from work or education, consumption of delayed antibiotics or other medications, adverse events. RESULTS: Among 565 eligible participants who were randomized (median age, 34 years [interquartile range, 26.0-45.5 year]; 75.2% women; 100% completed the intervention), 288 received dexamethasone; 277, placebo. At 24 hours, 65 participants (22.6%) in the dexamethasone group and 49 (17.7%) in the placebo group achieved complete resolution of symptoms, for a risk difference of 4.7% (95% CI, -1.8% to 11.2%) and a relative risk of 1.28 (95% CI; 0.92 to 1.78; P = .14). At 24 hours, participants receiving dexamethasone were not more likely than those receiving placebo to have complete symptom resolution. At 48 hours, 102 participants (35.4%) in the dexamethasone group vs 75 (27.1%) in the placebo group achieved complete resolution of symptoms, for a risk difference of 8.7% (95% CI, 1.2% to 16.2%) and a relative risk of 1.31 (95% CI, 1.02 to 1.68; P = .03). This difference also was observed in participants not offered delayed antibiotic prescription, for a risk difference of 10.3% (95% CI, 0.6% to 20.1%) and a relative risk of 1.37 (95% CI, 1.01 to 1.87; P = .046). There were no significant differences in any other secondary outcomes. CONCLUSIONS AND RELEVANCE: Among adults presenting to primary care with acute sore throat, a single dose of oral dexamethasone compared with placebo did not increase the proportion of patients with resolution of symptoms at 24 hours. However, there was a significant difference at 48 hours. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN17435450.
引用
- Hayward GN, Hay AD, Moore MV, et al. Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial. JAMA. 2017. PMID: 28418482. doi:10.1001/jama.2017.3417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。